Literature DB >> 8120872

Antiviral enantiomeric preference for 5'-noraristeromycin.

S M Siddiqi1, X Chen, S W Schneller, S Ikeda, R Snoeck, G Andrei, J Balzarini, E De Clercq.   

Abstract

In order to determine if the potent antiviral properties of (+/-)-5'-noraristeromycin reside in one of its enantiomers, an analysis of each enantiomer has been carried out. A five-step route to the (+)-stereoisomer is described from (+)-(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate, whereas the synthesis of the (-)-enantiomer had been reported previously from the same starting material. The (-)-2 and (+)-2 enantiomers were evaluated for antiviral activity against a large number of viruses and found to display an antiviral activity spectrum characteristic of (S)-adenosyl-L-homocysteine hydrolase inhibitors. The (-)-enantiomer retained the significant anticytomegalovirus properties previously reported for the racemic 2 and was, on the average, 10-fold more potent than (+)-2 in inhibiting virus replication, tumor cell growth, and (S)-adenosyl-L-homocysteine hydrolase activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120872     DOI: 10.1021/jm00030a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Substrate-dependent dihydroxylation of substituted cyclopentenes: toward the syntheses of carbocyclic sinefungin and noraristeromycin.

Authors:  May Xiao-Wu Jiang; Bohan Jin; Jennifer L Gage; Alain Priour; Gordon Savela; Marvin J Miller
Journal:  J Org Chem       Date:  2006-05-26       Impact factor: 4.354

3.  Carbocyclic 4'-Epiformycin.

Authors:  Jian Zhou; Minmin Yang; Akin Akdag; Haisheng Wang; Stewart W Schneller
Journal:  Tetrahedron       Date:  2008-01-07       Impact factor: 2.457

4.  A new synthesis and an antiviral assessment of the 4'-fluoro derivative of 4'-deoxy-5'-noraristeromycin.

Authors:  Xue-qiang Yin; Wei-kuan Li; Minmin Yang; Stewart W Schneller
Journal:  Bioorg Med Chem       Date:  2009-03-09       Impact factor: 3.641

5.  Historical perspectives in the development of antiviral agents against poxviruses.

Authors:  Erik De Clercq
Journal:  Viruses       Date:  2010-06-14       Impact factor: 5.818

6.  Uracil-Containing Heterodimers of a New Type: Synthesis and Study of Their Anti-Viral Properties.

Authors:  Anna A Maslova; Elena S Matyugina; Robert Snoeck; Graciela Andrei; Sergey N Kochetkov; Anastasia L Khandazhinskaya; Mikhail S Novikov
Journal:  Molecules       Date:  2020-07-23       Impact factor: 4.411

Review 7.  Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors.

Authors:  Liudmila A Alexandrova; Anastasia L Khandazhinskaya; Elena S Matyugina; Dmitriy A Makarov; Sergey N Kochetkov
Journal:  Microorganisms       Date:  2022-06-27

8.  Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.

Authors:  S M Siddiqi; K A Jacobson; J L Esker; M E Olah; X D Ji; N Melman; K N Tiwari; J A Secrist; S W Schneller; G Cristalli
Journal:  J Med Chem       Date:  1995-03-31       Impact factor: 7.446

9.  5'-Fluoro-5'-deoxyaristeromycin.

Authors:  Weikuan Li; Xueqiang Yin; Stewart W Schneller
Journal:  Bioorg Med Chem Lett       Date:  2007-10-30       Impact factor: 2.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.